Propiedad y actividad de insiders de Larimar Therapeutics, Inc. (LRMR): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $3.93 |
| Capitalización | $408M |
| Bolsa | NASDAQ |
| País | US |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $32.4M | $40.8M | $49.3M | $1.0M | $68.1M | $70.1M | $26.8M | $26.7M | $33.2M | $85.4M |
| Inversiones a Corto | $96.8M | $61.3M | $68.7M | 0 | $24.5M | 0 | $91.6M | $60.0M | $150.2M | $51.4M |
| Cuentas por Cobrar | $347000 | $946000 | $1.5M | $158000 | $32000 | $208000 | 0 | $332000 | $1.1M | $747000 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $130.9M | $104.9M | $121.3M | $4.8M | $98.0M | $72.2M | $120.7M | $90.2M | $195.3M | $142.0M |
| Inmovilizado Material | $661000 | $528000 | $375000 | $361000 | $5.0M | $4.5M | $3.7M | $3.8M | $3.7M | $2.7M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $131.6M | $105.5M | $121.8M | $5.2M | $104.7M | $78.7M | $126.4M | $95.9M | $200.2M | $145.8M |
| Cuentas por Pagar | 0 | 0 | $909000 | $3.5M | $2.6M | $1.7M | $1.7M | $1.3M | $2.4M | $5.2M |
| Deuda a Corto | $3.6M | 0 | $5.5M | 0 | 0 | 0 | 0 | 0 | 0 | $1.1M |
| Pasivos Corrientes | $9.9M | $7.3M | $13.3M | $5.9M | $9.0M | $8.8M | $10.7M | $9.5M | $24.4M | $64.8M |
| Deuda a Largo | 0 | $20.0M | $15.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $9.9M | $27.3M | $28.5M | $5.9M | $15.0M | $14.3M | $15.5M | $14.2M | $28.4M | $67.8M |
| Reservas | -$237.5M | -$289.6M | -$350.9M | -$23.1M | -$65.6M | -$116.2M | -$151.6M | -$188.6M | -$269.2M | -$434.8M |
| Patrimonio Neto | $121.7M | $78.2M | $93.3M | -$694000 | $89.7M | $64.4M | $110.9M | $81.7M | $171.8M | $78.1M |
| Deuda Total | $3.6M | $20.0M | $20.6M | $97000 | $6.5M | $6.0M | $5.4M | $5.5M | $5.1M | $4.1M |
| Deuda Neta | -$125.6M | -$82.1M | -$97.4M | -$912000 | -$86.1M | -$64.1M | -$113.0M | -$81.2M | -$178.3M | -$132.8M |
| Capital Circulante | $121.0M | $97.6M | $108.0M | -$1.1M | $89.0M | $63.4M | $110.0M | $80.7M | $170.9M | $77.2M |
Salud financiera
| Deuda / Patrimonio | 0.04 |
| Ratio corriente | 4.70 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -4.98 |
Rentabilidad
| Rentabilidad sobre capital | -137.39% |
| Rentabilidad sobre capital invertido | -135.25% |
| Rentabilidad sobre activos | -104.42% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ACIU · ALT · AMRN · ANNX · ANRO · DBVT · ENGN
Explorar sector: Healthcare · Biotechnology
Más secciones de LRMR: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones